EGFR and non-small cell lung carcinoma: The results of KEGG functional enrichment analysis showed that the active components affected NSCLC mainly through PI3K-Akt signaling pathway and the ErbB signaling pathway, indicating that compounds might play a major role in the treatment of NSCLC through the pathways (Figure 1D).